Lineage Cell Therapeutics
LCTX
LCTX
115 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 11 closing their positions.
Holders
115
Holders Change
-2
Holders Change %
-1.71%
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
36
Reduced
31
Closed
11
Calls
$349K
Puts
$139K
Net Calls
+$210K
Net Calls Change
+$210K